This was the stock's second consecutive day of losses.

Penserra Capital Management significantly slashed its Pfizer holdings by 67%, selling nearly 15,800 shares, leaving a stake ...

Mr. Mahatme brings decades of experience in strategic finance, capital formation, and operational leadership to support company's transformation and growth in autoimmune disease CAMBRIDGE, Mass., July ...

Pfizer faces adjusted financial forecasts as analysts lower earnings expectations for FY2025, signaling cautious optimism.

US regulators approved Moderna Inc.’s COVID-19 vaccine for children, but for a narrower group than before, continuing Robert ...

Stock indexes closed higher on Wall Street, enough to nudge the S&P 500 and the Nasdaq composite to more records. The S&P 500 ...

U.S. stock indexes are mixed as Wall Street sizes up a batch of corporate quarterly results. Delta Air Lines led a rally in airline stocks after releasing a solid outlook ...

Pfizer (PFE) and BioNTech (BNTX) challenge Moderna's patent win in London court over mRNA COVID-19 vaccine technology. Read ...

With a market cap of $145.7 billion, Pfizer Inc. (PFE) is a global, research-driven biopharmaceutical company, specializing ...

The Nasdaq composite inched fractionally higher in Tuesday's session. The S&P 500 shed less than 0.1%. Small caps led the ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...